Expanding Indications for the Human Papillomavirus Vaccine

In the US, the incidence of human papillomavirus (HPV)–related oropharyngeal cancer (OPC) has been growing at an alarming rate for the past 4 decades.1-3 In 2011, HPV-related OPC was predicted to surpass cervical cancer in annual incidence in the US by 2020.2 However, because of the continued…

Read the full article here

Related Articles